Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progression
Neurobiology of Disease · 2025
DOI: 10.1016/j.nbd.2025.106997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Cristina Spalletti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Institute, National Research Council (IN-CNR), 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Cerebral Cortex, Neuronal Plasticity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Glioblastoma (GBM) is a highly aggressive brain tumor that infiltrates surrounding brain tissue, profoundly affecting adjacent cortical areas. This study investigates how GBM reshapes the peritumoral cortex by examining plasticity changes in two GBM mouse models. Using optogenetic stimulation, we observed altered motor mapping and reduced cortical specificity in GBM mice compared to controls. Morphologically, GBM mice showed a reduction in dendritic spines, perineuronal nets, and inhibitory markers. Functionally, inhibitory circuits were markedly impaired, characterized by an increased frequency of spontaneous inhibitory currents and a decrease in their amplitude. Our findings highlight the critical role of inhibitory circuit disruption in driving cortical reorganization and loss of motor map specificity. The reduction of parvalbumin and somatostatin interneurons, degradation of perineuronal nets, and imbalance in the excitation/inhibition ratio contribute to maladaptive plasticity, increasing the risk of hyperexcitability and seizures. These insights offer a basis for developing therapeutic strategies aimed at restoring inhibitory function, mitigating GBM-induced cortical changes, and potentially improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroscience Institute, National Research Council (IN-CNR), 56124 Pisa, Italy.
- Neuroscience Institute, National Research Council (IN-CNR), 56124 Pisa, Italy; University of Pisa, Biology Department, 56124 Pisa, Italy.
- Bio@SNS, Scuola Normale Superiore, 56124 Pisa, Italy.
- Division of Physiology, Department of Pharmacology, Physiology and Microbiology Karl Landsteiner University of Health Sciences, 3500 Krems, Austria.
- Neuroscience Institute, National Research Council (IN-CNR), 56124 Pisa, Italy; Department of Biomedical Sciences, University of Padua, 35121 Padua, Italy.
- Neuroscience Institute, National Research Council (IN-CNR), 56124 Pisa, Italy; Department of Neuroscience, Psychology, Drugs and Child Health Area, School of Psychology, University of Florence, 50134 Florence, Italy.
Förderung
- Ministero dell'Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Spalletti, C., Scalera, M., Mori, E., Haddad, S., Mainardi, M., Cangi, D., Pillai, V., Parmigiani, E., Landi, S., Caleo, M., & Vannini, E. (2025). Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progression. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106997
Vancouver
Spalletti C, Scalera M, Mori E, Haddad S, Mainardi M, Cangi D, et al. Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progression. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106997
BibTeX
@article{Spalletti2025,
author = {Spalletti, Cristina and Scalera, Marta and Mori, Elisabetta and Haddad, Sabrin and Mainardi, Marco and Cangi, Daniele and Pillai, Vinoshene and Parmigiani, Elena and Landi, Silvia and Caleo, Matteo and Vannini, Eleonora},
title = {Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progression},
journal = {Neurobiology of Disease},
year = {2025},
doi = {10.1016/j.nbd.2025.106997}
}
EUVIMED